Concepedia

Lew Pliamm

LP

Statistics

Publications

5

Citations

401

H-Index

5

Active since

2014

Affiliations

University of Toronto(Current)

Lew Pliamm is an author at University of Toronto specializing in clinical pharmacology, pharmacotherapy, and pharmacology.

Publications per year

2014–2022

5

Publications

5

Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial

Markus P. Schlaich, M Bellet, Michael A. Weber et al. · The Lancet · 2022 · 227 citations · Full text

Medicine, Cardiology, Pharmacology +14

Clinical utility of combinatorial pharmacogenomic testing in depression: A Canadian patient- and rater-blinded, randomized, controlled trial

Arun K. Tiwari, Clement C. Zai, C. Anthony Altar et al. · Translational Psychiatry · 2022 · 60 citations · Full text

Medicine, Pharmacotherapy, Psychiatry +17

Retreatment With Varenicline for Smoking Cessation in Smokers Who Have Previously Taken Varenicline: A Randomized, Placebo-Controlled Trial

David Gonzales, Peter Hájek, Lew Pliamm et al. · Clinical Pharmacology & Therapeutics · 2014 · 50 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16

Family physician-led, team-based, lifestyle intervention in patients with metabolic syndrome: results of a multicentre feasibility project

Khursheed N. Jeejeebhoy, Rupinder Dhaliwal, Daren K. Heyland et al. · CMAJ Open · 2017 · 36 citations · Full text

Agriculture, Family Medicine, Nutrition +16

Effects of anacetrapib on plasma lipids in specific patient subgroups in the DEFINE (Determining the Efficacy and Tolerability of CETP INhibition with AnacEtrapib) trial

Eliot A. Brinton, Uma Kher, Sukrut Shah et al. · Journal of clinical lipidology · 2014 · 28 citations

Medicine, Pharmacology, Pharmacotherapy +11

1–5 of 5